Immunofluorescence Assay Market - Global Industry Analysis

Immunofluorescence Assay Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Biotechnology Report Format : PDF Report Code: ZMR-5838 Status : Upcoming

Description

Global Immunofluorescence Assay Market: Overview

Immunofluorescence is an antibody and antigen reaction in which antibodies are well labeled with a fluorescent dye and it is identified with the help of a fluorescent microscope. Some of the fluorochromes that are widely used are calcofluor white, rhodamine, lissamine, and acridine orange. However, various factors like cross-reactivity, sensitivity, flexibility, complexity, cost, time consumed, and others affects the immunofluorescence assays. The immunofluorescence assays are performed both ways direct and indirect immunofluorescence. It is a specific technique widely used for light microscopy with a fluorescence microscope and utilized mostly on microbial samples.

Global Immunofluorescence Assay Market: Growth Factors

One of the major factors driving the global immunofluorescence assay market is the growing prevalence of chronic diseases across the globe. The surging research and development activities to innovate new ways for testing are boosting the growth of the global immunofluorescence assay market. Moreover, the increasing burden of diseases like neurological disorders, infectious diseases, cancer, diabetes, cardiovascular diseases, autoimmune diseases, and many others globally has positively shaped the trajectory of the global immunofluorescence assay market during the forecast period. The growing investments by the major market players for innovating more safer and effective tests kit are bolstering the growth of the global immunofluorescence assay market. The extensive research to enhance the quality of test kits and protocols to strengthen the global market is supporting the growth of the global immunofluorescence assay market.

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Immunofluorescence Assay Market: Segmentation

The global immunofluorescence assay market can be segmented into end-users, diseases, type, product, and region.

By end-users, the market can be segmented into hospitals & diagnostic centers, contract research organizations, pharmaceutical & biotechnology companies, academic & research institutes, and others. The pharmaceutical & biotechnology companies segment holds the largest share in the global immunofluorescence assay market due to the growing utilization of the technology in the drug development and discovery process.

By diseases, the market can be segmented into autoimmune diseases, cardiovascular diseases, infectious diseases, cancer, and others. The cancer segment holds hegemony over others due to the growing prevalence of the diseases globally. Moreover, the wide adoption of the technique for diagnosis and study of the diseases also supports the growth of the segment.

By type, the market can be segmented into direct immunofluorescence and indirect immunofluorescence. The indirect immunofluorescence segment dominates the global immunofluorescence assay market due to its advantages like low cost as compared to the direct immunofluorescence, better amplification of the signal, flexibility, and sensitivity.

By product, the market can be segmented into consumables & accessories, instruments, kits, reagents, and antibodies. The kit segment accounts for the largest share in the global immunofluorescence assay market owing to the growing demand for complete testing solutions from one provider.

Global Immunofluorescence Assay Market: Regional analysis

North America accounts for the largest share in the global immunofluorescence assay market due to the rising incidences of infectious and chronic illness cases. Moreover, the growing research and development activities coupled with the increasing investments further supports the growth of the regional market.

Europe is expected to witness significant growth with high CAGR during the forecast period due to the growing need for improved products for healthcare and academic purposes.

Asia Pacific is also growing fast in the global immunofluorescence assay market due to the emergence of prominent market players in the region.

Global Immunofluorescence Assay Market: Competitive Players

Some of the major companies in the global immunofluorescence assay market are Danaher, Sino Biological Inc., Enzo Life Sciences, Inc., Agilent Technologies, Inc., BD, Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam plc., Thermo Fisher Scientific Inc., MaxVision Biosciences Inc, AESKU GROUP GmbH, Elabscience, Inc., EpiGentek Group, Abnova Corporation, J. Mitra & Co. Pvt. Ltd., Celebs, Zyagen, Inc., Agilent Technologies, Bruker Corporation, Nikon Corporation, Olympus Corporation, Dickinson and Company, Becton, Enzo Biochem, Inc., Maravai LifeSciences, Danaher Corporation, Sino Biological, Inc., MEDIPAN GmbH, Cell Signaling Technology, Inc., Werfen Company, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam plc, and Thermo Fisher Scientific, Inc.

Global Immunofluorescence Assay Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content


Frequently Asked Questions

One of the major factors driving the global immunofluorescence assay market is the growing prevalence of chronic diseases across the globe. The surging research and development activities to innovate new ways for testing are boosting the growth of the global immunofluorescence assay market. What are the key players leveraging immunofluorescence assay market growth?

Some of the major companies in the global immunofluorescence assay market are Danaher, Sino Biological Inc., Enzo Life Sciences, Inc., Agilent Technologies, Inc., BD, Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam plc., Thermo Fisher Scientific Inc., MaxVision Biosciences Inc, AESKU GROUP GmbH, Elabscience, Inc., EpiGentek Group, Abnova Corporation, J. Mitra & Co. Pvt. Ltd.

North America accounts for the largest share in the global immunofluorescence assay market due to the rising incidences of infectious and chronic illness cases. Moreover, the growing research and development activities coupled with the increasing investments further supports the growth of the regional market.

 

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social